Haberlere Geri Dön

İçki haberleri

EFSA Topic Page Highlights Zinc L-Carnosine Supplement Context

Nutranexa Haberleri tarafından |

EFSA lists a scientific opinion on zinc L-carnosine as a novel food and its zinc bioavailability in the context of the EU supplement directive.

European supplement dossier with mineral complex sample, blank bioavailability chart, and quality-review folders on a daylight bench

Nutranexa tarafından oluşturulan görüntü

What Was Reported

EFSA's food and novel-food pages list a scientific opinion on the safety of zinc L-carnosine as a novel food and the bioavailability of zinc from that source in the context of Directive 2002/46/EC, published June 17, 2026.

The listing is specific to a zinc source and its intended supplement context. It should not be read as a general opinion on all food ingredients or phospholipids.

Ingredient Buyer Context

European supplement dossier with mineral complex sample, blank bioavailability chart, and quality-review folders on a daylight bench with a closer quality-review detail

The sourcing lesson is to connect the ingredient identity, source form, proposed use, and regulatory route. A PS buyer should maintain the same discipline when reviewing a customer request for a source statement, food-supplement status, or market-entry document.

The source concerns the named study, company, agency, or market development. It should not be expanded into a medical treatment claim, a universal ingredient result, or a guarantee about a supplier or finished product.

Nutranexa Takeaway

Nutranexa does not supply zinc L-carnosine and makes no claim from this opinion. The item is included as regulatory monitoring.

For a product-specific discussion, provide the target market, application, source preference, PS grade, annual quantity, packaging, and required documents. Nutranexa can then discuss the relevant product and quality evidence without assuming facts that are not in the current controlled file.

Kaynaklar